For example, PAHDNA adducts are observed in lung tissues, and p53 tumor suppressor mutations in lung tumors resemble the damage created by PAH diol epoxide metabolites in vitro
Inc., AstraZeneca PLC, Imperial Brands plc, GlaxoSmithKline plc, British American Tobacco plc, Dr Reddys Laboratories Ltd, Cipla Ltd, Cambrex Corp, Fertin Pharma, 22nd Century Group Inc., McNeil AB, Chrono Therapeutics Inc., Smoke Away LLC Global Smoking Cessation And Nicotine De-Addiction Products Market Trends and Insights Major companies operating in the smoking cessation and nicotine de-addiction products market are focusing on developing plant-derived receptor-targeted pharmacotherapies, which interact with nicotinic acetylcholine receptors in the brain to reduce cravings and nicotine reward, supporting controlled cessation
Product Form Insights Soft packs are anticipated to hold a share of approximately 49.1% in 2025 as they are lightweight, flexible, and cost-efficient while providing adequate protection for cigarettes and HTP sticks
These vapes offer all the flavor and most of the simplicity of a disposable at an even better value
